4//SEC Filing
Rolph Timothy 4
Accession 0001193125-25-301155
CIK 0001744659other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 6:03 AM ET
Size
23.5 KB
Accession
0001193125-25-301155
Insider Transaction Report
Form 4
Rolph Timothy
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-25$28.35/sh+3,527$99,990→ 132,998 total - Exercise/Conversion
Common Stock
2025-11-25$6.36/sh+43,064$274,059→ 176,062 total - Exercise/Conversion
Common Stock
2025-11-25$21.09/sh+4,284$90,350→ 180,346 total - Exercise/Conversion
Common Stock
2025-11-25$0.61/sh+2,796$1,720→ 183,142 total - Exercise/Conversion
Common Stock
2025-11-25$0.61/sh+94,268$57,975→ 277,410 total - Exercise/Conversion
Common Stock
2025-11-25$21.10/sh+4,739$99,993→ 282,149 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−2,796→ 0 totalExercise: $0.61Exp: 2028-07-29→ Common Stock (2,796 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−94,268→ 0 totalExercise: $0.61Exp: 2028-10-17→ Common Stock (94,268 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−43,064→ 0 totalExercise: $6.36Exp: 2029-12-12→ Common Stock (43,064 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−4,284→ 0 totalExercise: $21.09Exp: 2029-12-12→ Common Stock (4,284 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−3,527→ 0 totalExercise: $28.35Exp: 2030-12-07→ Common Stock (3,527 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−4,739→ 0 totalExercise: $21.10Exp: 2031-12-07→ Common Stock (4,739 underlying)
Footnotes (1)
- [F1]The options are vested and currently exercisable.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001779479
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 6:03 AM ET
- Size
- 23.5 KB